On the other hand, survival analysis from Kaplan‐Meier Plotter revealed that the expression levels of SLAMF3 showed no significant correlation with OS of CRC patients (n = 1061) (Figure 9I). The gene discussed is LY9; the disease is colorectal carcinoma.